Gain Therapeutics, Inc. (GANX)
NASDAQ: GANX · Real-Time Price · USD
1.850
-0.100 (-5.13%)
At close: Apr 28, 2026, 4:00 PM EDT
1.860
+0.010 (0.54%)
After-hours: Apr 28, 2026, 7:19 PM EDT
Gain Therapeutics Employees
As of December 31, 2025, Gain Therapeutics had 21 total employees, including 20 full-time and 1 part-time employees. The number of employees decreased by 4 or -16.00% compared to the previous year.
Employees
21
Change (1Y)
-4
Growth (1Y)
-16.00%
Revenue / Employee
n/a
Profits / Employee
-$960,052
Market Cap
78.15M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Champions Oncology | 213 |
| Gossamer Bio | 162 |
| Sangamo Therapeutics | 142 |
| Adicet Bio | 102 |
| PolyPid | 75 |
| eXoZymes | 32 |
| NeurAxis | 24 |
| Filana Therapeutics | 20 |
GANX News
- 4 days ago - Gain Therapeutics Announces Oral Presentation at 3rd International GBA1 Meeting 2026 - GlobeNewsWire
- 4 weeks ago - Gain Therapeutics Reports Financial Results for the Fourth Quarter and Year End 2025 and Provides Corporate Update - GlobeNewsWire
- 5 weeks ago - Gain Therapeutics Transcript: The 38th Annual Roth Conference - Transcripts
- 5 weeks ago - Gain Therapeutics to Present at the 38th Annual ROTH Conference - GlobeNewsWire
- 5 weeks ago - Gain Therapeutics Presents Additional Clinical and Biomarker Data from Phase 1b Clinical Study of GT-02287 and Preclinical Data from Novel Chemical Series at AD/PD 2026 - GlobeNewsWire
- 6 weeks ago - Gain Therapeutics Announces Presentations at AD/PDTM 2026 and Provides U.S. FDA Regulatory Update - GlobeNewsWire
- 2 months ago - Gain Therapeutics to Present at Oppenheimer 36th Annual Healthcare Life Sciences Conference - GlobeNewsWire
- 3 months ago - Gain Therapeutics Announces Announces Conference Participation During J.P. Morgan Healthcare Conference Week - GlobeNewsWire